| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c04036bba1a94348a49305ea1aa341e0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-20 |
| filingDate |
2016-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0c1b81b99f398510dc1ad49542f647e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51f874feb0ab2b53eca2a0d658ac1ea6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afa8cef89b3ee5db4368c12812b8422a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab4aa9de91873539ec777251c069c01b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a2cf55fda500c44fe576e37f83a63e2 |
| publicationDate |
2021-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2750040-C2 |
| titleOfInvention |
Compositions and methods for diagnosing lyme disease and predicting elimination of lyme disease-causing spirochetes after treatment |
| abstract |
FIELD: medicine. n SUBSTANCE: group of inventions relates to the diagnosis and prognosis of Lyme disease. The composition for the diagnosis or prognosis of Lyme disease contains 5 isolated FlaB peptides with Borrelia T-cell epitopes having amino acid sequences SEQ ID NO: 1-5; 13 isolated DbpB peptides with a Borrelia T-cell epitope having the amino acid sequence SEQ ID NO:6-18; 13 isolated peptides p66 with a T-cell epitope of Borrelia having amino acid sequences SEQ ID NO:19-31; 2 isolated OspC peptides with a Borrelia T-cell epitope having the amino acid sequences SEQ ID NO:32-33. Also disclosed is a method for detecting Lyme disease in a subject, a composition containing a set of nucleic acids encoding peptides, a set of nucleic acid-based vectors for host cell transformation, and a host cell for the expression of nucleic acids. n EFFECT: improved diagnostic and prognostic assessment of Lyme disease. n 43 cl, 1 dwg, 7 tbl, 1 ex |
| priorityDate |
2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |